436PPreliminary results of the first-in-human, dose-finding...

Annals of Oncology 2018 / 10 Vol. 29; Iss. suppl_8

436PPreliminary results of the first-in-human, dose-finding PROCLAIM-CX-072 trial evaluating the PD-L1 probody therapeutic CX-072 in combination with ipilimumab (ipi) in patients (pts) with advanced solid tumors

Plummer, R, Sanborn, R E, de Vries, E G E, Lorusso, P, Arkenau, H-T, Uboha, N, Wydmanski, J, Fidler, M J, Boni, V, Garcia-Corbacho, J, Humphrey, R, Will, M, Autio, K A, El-Khoueiry, A B, Menke-van der
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
29
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy279.423
Date:
October, 2018
File:
PDF, 75 KB
english, 2018
Conversion to is in progress
Conversion to is failed